Characterization of "Bamboo" and Other Vocal Cord Lesions Responsible for Dysphonia in Patients With Systemic Autoimmune Diseases (BAMBOO)

Launched by UNIVERSITY HOSPITAL, BREST · Jan 13, 2025

Keywords

ClinConnect Summary

The BAMBOO clinical trial is studying the types of vocal cord lesions that can cause problems with speaking, known as dysphonia, in patients who have systemic autoimmune diseases like rheumatoid arthritis or lupus. The researchers want to find out which specific vocal cord issues are causing these speaking difficulties, whether patients experience delays in getting a diagnosis, and how these problems are treated. This study is important because it aims to improve understanding and management of dysphonia in people with these conditions.

To take part in this study, participants must be at least 18 years old and have a systemic autoimmune disease along with a vocal cord lesion that has been identified. They should also be experiencing dysphonia. The study is currently looking for participants, and those who join will have their medical records reviewed to gather information on their condition. Overall, this research could help enhance care for individuals dealing with vocal issues related to autoimmune diseases.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients aged 18 years or older
• • With a systemic autoimmune disease : rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis, primary Sjogren disease, sarcoidosis, vasculitis, myositis, Still disease, Sharp syndrome.
• • Suffering from dysphonia.
• • With a cord vocal/laryngeal lesion highlighted.
• Exclusion Criteria:
• • Patients under the age of 18 years
• • Dysphonia due to a cord vocal palsy related to a neurological condition or malignancy
• • History of cervical radiation
• • History of oro-tracheal intubation
• • Laryngeal cancer
• • Participation deny
• • Impossibility of consent
• • Patients with legal protection